Catalyst Wire Dossier Catalyst Wire Dossier

Topical oxybutynin 10%

oxybutynin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Topical oxybutynin 10%, covering 2016-11-25 to 2016-11-25. Get the full timeline:

Most recent: Clinical Trial Update: The Use of Topical Oxybutynin 10% for Treating Primary Focal Hyperhidrosis-axillary, Palmar and Plantar. [NA]

See pricing